Early granulomatous foreign body reactions to a novel alginate dermal filler: The system's failure?

Journal of the European Academy of Dermatology and Venereology

Volumn 27, Issue 1, 2013, Pages 121-123

  Schuller Petrovic S ^a   Pavlovic M D ^b   Schuller, S S ^a   Schuller Lukic B ^a   Neuhold, N ^c  

^a VENEX Vein and Dermatology Centre   (Austria)

^b Dermatology Centre Parmova   (Slovenia)

^c Rudolfinerhaus ^*  (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

FILLER;

ADULT; ARTICLE; CASE REPORT; ECHOGRAPHY; EYE REDNESS; FEMALE; FOREIGN BODY REACTION; GRANULOMATOSIS; GRANULOMATOUS FOREIGN BODY REACTION; HISTOPATHOLOGY; HUMAN; PRIORITY JOURNAL; SWELLING;

ADULT; ALGINATES; CELLULOSE; COSMETIC TECHNIQUES; DERMATOLOGIC AGENTS; ESTHETICS; FEMALE; FOLLOW-UP STUDIES; FOREIGN-BODY REACTION; GLUCURONIC ACID; GRANULOMA, FOREIGN-BODY; HEXURONIC ACIDS; HUMANS; INJECTIONS, SUBCUTANEOUS; LACTIC ACID; MANNITOL; MIDDLE AGED; RISK ASSESSMENT; SAMPLING STUDIES; SKIN AGING; TIME FACTORS; TREATMENT OUTCOME;

EID: 84872831130     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2011.04264.x     Document Type: Article

References (16)

1. American Society for Aesthetic Plastic Surgery. Cosmetic Surgery National Data Bank 2009 Statistics. [WWW document] 2009. URL http://www.surgery.org/ sites/default/files/2009stats.pdf (last accessed: 7 February 2011).
2. Wilson KA,. Novabel reshapes the face of aesthetic medicine. The European Aesthetic Guide, Merz Supplement, January 2010; 1-8.
3. Skjåk-Braek G,. Alginates: biosyntheses and some structure-function relationships relevant to biomedical and biotechnological applications. Biochem Soc Trans 1992; 20: 27-33.
4. Rokstad AM, Holtan S, Strand B, et al. Microencapsulation of cells producing therapeutic proteins: optimizing cell growth and secretion. Cell Transplant 2002; 11: 313-324.
5. ®? [WWW document]. URL http://www.novabel.co.uk/index.php?option=com-content&view=article&id= 4&Itemid=100&phpMyAdmin=56bb66d61a13bd22bda0953f17d8489b (last accessed: 7 February 2011).
6. Hirsch RJ, Stier M,. Complications of soft tissue augmentation. J Drugs Dermatol 2008; 7: 841-845.
7. Rudolph CM, Soyer HP, Schuller-Petrovic S, Kerl H,. Foreign body granulomas due to injectable aesthetic microimplants. Am J Surg Pathol 1999; 23: 113-117.
8. Hoffmann C, Schuller-Petrovic̈ S, Soyer HP, Kerl H,. Adverse reactions after cosmetic lip augmentation with permanent biologically inert implant materials. J Am Acad Dermatol 1999; 40: 100-102.
9. Requena L, Requena C, Christensen L, Zimmermann US, Kutzner H, Cerroni L,. Adverse reactions to injectable soft tissue fillers. J Am Acad Dermatol 2011; 64: 1-34.
10. Halberstadt C, Austin C, Rowley J, et al. A hydrogel material for plastic and reconstructive applications injected into the subcutaneous space of a sheep. Tissue Eng 2002; 8: 309-319.
11. Ménard M, Dusseault J, Langlois G, et al. Role of protein contaminants in the immunogenicity of alginates. J Biomed Mater Res B Appl Biomater 2010; 93: 333-340.
12. Smidsrod O, Skjak-Braek G,. Alginate as immobilization matrix for cells. Trends Biotech 1990; 7: 71-80.
13. Biocompatibles. CE mark approval for cosmetic dermal filler bead. [WWW document] 2009. URL http://www.biocompatibles.com/media/press-releases/2009/19- 03-2009.aspx (last accessed: 8 February 2010).
14. Biesman B,. Caution in the use of soft tissue injectable filler in the tear trough region. Aesthet Surg J 2010; 30: 269.
15. Fischer J, Metzler G, Schaller M,. Cosmetic permanent fillers for soft tissue augmentation: a new contraindication for interferon therapies. Arch Dermatol 2007; 143: 507-510.
16. Descamps V, Landry J, Frances C, Marinho E, Ratziu V, Chosidow O,. Facial cosmetic filler injections as possible target for systemic sarcoidosis in patients treated with interferon for chronic hepatitis C: two cases. Dermatology 2008; 217: 81-84.